Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte vs Albumin for Fluid Resuscitation in Major Burns
NCT01689506Phase 4Terminated
- Sponsor
- Fresenius Kabi
- Start
- Dec 2012
- Primary completion
- Sep 2013
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in burn injury, sponsored by Fresenius Kabi. Started Dec 2012; status: terminated.
02
Drugs
hetastarch
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01689506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689506.